Alector
Latest round
- Series E
Last raised
- Jul 2018
Total raised
- $195M
Investors
- 18
About Alector
Alector Inc.Alector Inc. was founded in 2013 in San Francisco, US, by Arnon Rosenthal and Errik Anderson. The company specializes in therapeutic innovation for neurodegenerative diseases.Alector Therapeutics specializes in developing therapies aimed at neurodegenerative diseases, including frontotemporal dementia, Alzheimer’s, and ALS. Its core products focus on removing toxic proteins, replacing deficient proteins, and restoring immune and nerve cell function, utilizing advanced technologies like the Alector Brain Carrier (ABC) for targeted drug delivery across the blood-brain barrier.S.In 2024, Alector Inc.56 mn. The company is actively designing new products targeting neurodegenerative conditions and intends to penetrate additional markets within the next few years.
Who invested in Alector
18 investors across 4 rounds
See all investors in Alector
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Alector
Who invested in Alector?
Alector has 18 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Alector raised?
Alector has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Alector last raise money?
Alector's most recent round on record is a Series E, in Jul 2018.
What does Alector do?
Alector is a biotechnology company.
Where is Alector headquartered?
Alector is headquartered in San Francisco, US.
Which VCs invest in companies like Alector?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Alector's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series E
Raising like Alector? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.